Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues

REFERENCES

• Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced airways diseases. Free Radic Biol Med 1996; 21: 669–681.
   PubMed Web of Science ®Google Scholar
• Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airways disease. Am J Physiol 1999; 277: L1067–L1088.
   PubMed Web of Science ®Google Scholar
• Rochelle LG, Fischer BM, Adler KB. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 1998; 24: 863–868.
   PubMed Web of Science ®Google Scholar
• Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819–1828.
   PubMed Web of Science ®Google Scholar
• Church T, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64: 111–126.
   PubMed Web of Science ®Google Scholar
• Pryor WA, Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxides, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 1993; 686: 12–28.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Church DF, Pryor WA. Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic Biol Med 1989; 7: 9–15.
   PubMed Web of Science ®Google Scholar
• Zang LY, Stone K, Pryor WA. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med 1995; 19: 161–167.
   PubMed Web of Science ®Google Scholar
• Uchida K, Shiraishi M, Naito Y, Toni N, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. J Biol Chem 1999; 274: 2234–2242.
   PubMed Web of Science ®Google Scholar
• Parola M, Bellomo G, Robino G, Barrera G, Dianzani MU. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxidant Redox Signal 1999; 1: 255–284.
   PubMed Web of Science ®Google Scholar
• Lawson JA, Rokach J, FitzGerald GA. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 1999; 274: 24441–24444.
   PubMed Web of Science ®Google Scholar
• Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19–25.
   PubMed Web of Science ®Google Scholar
• Pratico D, Basili S, Vieri M, Cordova C, Violi F, FitzGerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostanean index of oxidantstress. Am J Respir Crit Care Med 1998; 158: 1709–1714.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Roberts U. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997; 36: 1–21.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81–128.
   PubMed Web of Science ®Google Scholar
• Cahuana GM, Tejedo JR, Jimenez J, Ramirez R, Sobrino F, Bedoya FJ. Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells. Biochem Pharmacol 2003; 6: 1963–1971.
   Google Scholar
• Kehrer JP, Biswal SS. The molecular effects of acrolein. Toxicol Sci 2000; 57: 6–15.
   PubMed Web of Science ®Google Scholar
• Horvath I. Exhaled breath condensate contains more than only volatiles. Eur Respir J2003; 22: 187-188.
   Google Scholar
• Montuschi P, Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002; 23: 232–237.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693–1722.
   PubMed Web of Science ®Google Scholar
• Rahman I, Kelly F. Biomarkers in breath condensate: a promising new non-invasive technique in free radical research. Free Radic Res 2003; 37: 1253–1266.
   PubMed Web of Science ®Google Scholar
• Montuschi P. Indirect monitoring of lung inflammation. Nat Rev Drug Discovery 2002; 1: 238–242.
   PubMed Web of Science ®Google Scholar
• Scheideler L, Manke HG, Schwulera U, Inacke 0, Hammerle H. Detection of non-volatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993; 148: 778–784.
   Google Scholar
• Montuschi P, Corradi M, Giabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216–220.
   PubMed Web of Science ®Google Scholar
• Mutlu GM, Garey KW, Robbins RA, Danziger IH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001; 164: 731–737.
   PubMed Web of Science ®Google Scholar
• Corradi M, Rubinstein I, Andreoli R et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1380–1386.
   PubMed Web of Science ®Google Scholar
• Griese M, Latzin P, Beck J. A non-invasive method to collect nasally exhaled air condensate in humans of all ages. Eur J Clin Invest 2001; 31: 915–920.
   PubMed Web of Science ®Google Scholar
• Montuschi P. Indirect monitoring of lung inflammation. Nat Rev Drug Discovery 2002; 1: 238–242.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 505–513.
   PubMed Web of Science ®Google Scholar
• Gallati H, Pracht J. Horseradish peroxidase: kinetic studies and optimisation of peroxidase activity determination using the substrates H202 and 3,3',5,5'-tetramethylbenzidine. J Clin Chem Clin Biochem 1985; 23: 453–460.
   PubMedGoogle Scholar
• Ruch W, Cooper PH, Baggiolini M. Assay of H202 production by macrophages and neutrophils with homovanillic acid and horseradish peroxidase. J Immunol Methods 1983; 63: 347–357.
   PubMed Web of Science ®Google Scholar
• Janzen EG. Spin trapping. Methods Enzymol 1984; 105: 188–198.
   PubMed Web of Science ®Google Scholar
• Buettner GR, Mason RP. Spin-trapping methods for detecting superoxide and hydroxyl free radicals in vitro and in vivo. Methods Enzymol 1990; 186: 127–133.
   PubMed Web of Science ®Google Scholar
• Berliner LJ, Khramtsov V, Fujii H, Clanton TL. Unique in vivo applications of spin traps. Free Radic Biol Med 2001; 30: 489–499.
   PubMed Web of Science ®Google Scholar
• Tordo P. Spin-trapping: recent developments and applications. Electron Paramagnetic Resonance 1998; 16: 117–144.
   Google Scholar
• Nicholson JK, Lindon JC, Holmes E. Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181–1189.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Wilson ID. High resolution proton NMR spectro-scopy of biological fluids. Prog NMR Spectrosc 1989; 21: 449–501.
   Web of Science ®Google Scholar
• El-Deredy W. Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: a review. NMR Biomed 1997; 10: 99–124.
   PubMed Web of Science ®Google Scholar
• Holmes E, Foxall PJ, Nicholson JK et al. Automatic data reduction and pattern recognition methods for analysis of '1-1 nuclear magnetic resonance spectra of human urine form normal and pathological states. Anal Biochem 1994; 220: 284-296.
   Google Scholar
• Holmes E, Nicholls AW, Lindon JC. Chemometric models for toxicity classification on NMR spectra of biofluids. Chem Res Toxicol 2000; 13: 471–478.
   PubMed Web of Science ®Google Scholar
• Brindle JT, Antti H, Homes E et al. Rapid and non-invasive diagnosis of the presence and severity of coronary heart disease using 1 H-NMR-based metabonomics. Nat Med 2002; 8:
   Google Scholar
• Murtz M, Frech B, Urban W. High resolution cavity leak-out absorption spectroscopy in the 10 gm region. Appl Phys 1999; 68: 243–249.
   Web of Science ®Google Scholar
• Razola SS, Ruiz BL, Diez NM, Mark HB, Kauffmann JM.63.Hydrogen peroxide sensitive amperometric biosensor based on horseradish peroxidase entrapped in a polypyrrole electrode. Biosens Bioelectron 2002; 17: 921–928.
   PubMed Web of Science ®Google Scholar
• Thanachasai S, Rokutanzano S, Yoshida S, Watanabe T. Novel64.hydrogen peroxide sensors based on peroxidase-carrying poly[pyrrole-co-[4-(3-pyrrolyl)butanesulfonate] copolymer films. Anal Sci 2002; 18: 773–777.
   PubMed Web of Science ®Google Scholar
• Rahman I. Reproducibility of oxidative stress biomarkers in breath65.condensate: are they reliable? Eur Respir J2004; 23: 183-184.
   Google Scholar
• Hunt J. Exhaled breath condensate: an evolving tool for non-invasive evaluation of lung disease. J Allergy Clin Immunol 2002;
   Google Scholar
• Horvath I, Donnelly LE, Kiss A et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998; 158: 1042–1046.
   PubMed Web of Science ®Google Scholar
• Effros RM, Hoagland KW, Bosbous Met al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Grit Care Med 2002; 165: 663–669.
   PubMed Web of Science ®Google Scholar
• Vass G, Huszar E, Barat E et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. Am J Respir Crit Care Med 2003; 167: 850–855.
   Google Scholar
• Risby TH. Further discussion on breath condensate analysis. Am J Respir Crit Care Med 2003; 167: 1301–1302.
   PubMed Web of Science ®Google Scholar
• Hunt JF, Erwin E, Palmer L et al. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J
   Google Scholar
• Gessner C, Kuhn H, Seyfarth HJ et al. Factors influencing breath condensate volume. Pneumologie 2001; 55: 414–419.
   PubMedGoogle Scholar
• Dohlman AW, Black BR, Royall J. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric71.patients with asthma. Am Rev Respir Dis 1993; 148; 955–960.
   PubMed Web of Science ®Google Scholar
• Nowak D, Kasielski M, Pietras T, Bialasiewicz P. Antczak A. Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD. Monaldi 72. Arch Chest Dis 1998; 53: 268–273.
   Google Scholar
• Nowak D, Antczak A, Krol M et al. Increased content of hydrogen peroxide in expired breath of cigarette smokers. Eur Respir J1996; 73.9: 652-657.
   Google Scholar
• Dekhuijzen PN, Aben KK, Dekker I et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic74.obstructive pulmonary disease. Am J Respir Grit Care Med 1996; 154: 813–816.
   PubMed Web of Science ®Google Scholar
• Hoidal JR, Fox RB, LeMarbe PA, Perri R, Repine JE. Altered75.oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am Rev Respir Dis 1981;76.123: 85–89.
   Google Scholar
• Deaton CM, Marlin DJ, Smith NC et al. Breath condensate hydrogen peroxide correlates with both airway cytology and77.epithelial lining fluid ascorbic acid concentration. Free Radic Res 2004; 38: 201–208.
   PubMed Web of Science ®Google Scholar
• Wilhelm J, Vankova M, Maxova H, Siskova A. Hydrogen peroxide78.production by alveolar macrophages is increased and its concentration is elevated in the breath of rats exposed to hypoxia: relationship to lung lipid peroxidation. Physiol Res 2003; 52: 79.327–332.
   PubMedGoogle Scholar
• Antczak A, Kurmanowska Z, Kasielski M, Nowak D. Inhaled glucocorticosteroids decrease hydrogen peroxide in expired air condensate in asthmatic children. Respir Med 2000,94: 416-421. Respir J1997; 10: 519-521.
   Google Scholar
• Jobsis Q, Raatgeep HC, Hermans PWM, de Jongste JC. Hydrogen80.peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J1997; 10: 519-521.
   Google Scholar
• Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003; 111: 313–320.
   PubMed Web of Science ®Google Scholar
• Kietzman D, Kah R, Muller M, Burchardi H, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993; 19: 78–81.
   PubMed Web of Science ®Google Scholar
• Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001; 95: 448–456.
   PubMed Web of Science ®Google Scholar
• Antczak A, Gorski P. Antibiotic treatment decreases hydrogen peroxide and thiobarbituric acid reactive substances in expired air condensate in infectious exacerbation of bronchial asthma. Int Rev Allergol Clin Immunol 2000; 6: 52–55.
   Google Scholar
• Luczynska M, Szkudlarek U, Dziankowska-Barthowiak B et al. Elevated exhalation of hydrogen peroxide in patients with systemic sclerosis. Eur J Clin Invest 2003; 33: 274–279.
   PubMed Web of Science ®Google Scholar
• van Beurde WJ, Harff GA, Dekhuijzen PN, van den Bosch MJ, Creemers JP, Smeenk FW. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002; 96: 197–203.
   PubMed Web of Science ®Google Scholar
• Jobsis RQ, Schellekens SL, Fakkel-Kroesbergen A, Raatgeep RH, de Jongste JC. Hydrogen peroxide in breath condensate during a common cold. Mediators Inflamm 2001; 10: 351–354.
   PubMed Web of Science ®Google Scholar
• Van Hoydonck PGA, Wuyts WA, Vanaudenaerde BM, Shouten EG, Dupont LJ, Temme EHM. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004; 23: 189–192.
   PubMed Web of Science ®Google Scholar
• Dekhuijzen PN, Aben KK, Dekker I et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Grit Care Med 1996; 154: 813–816.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Collins JV, Ciabattoni Get al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Grit Care Med 2000; 162: 1175–1177.
   PubMed Web of Science ®Google Scholar
• Nowak D, Kalucka S, Bialasiewicz P, Krol M. Exhalation of H202 and thiobarbituric acid reactive substances (TEARS) by healthy subjects. Free Radic Biol Med 2001; 30: 178–186.
   PubMed Web of Science ®Google Scholar
• Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J1993; 6: 1368-1370.
   Google Scholar
• Silkoff PE, Sylvester JT, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Grit Care Med 2000; 161: 1218–1228.
   PubMed Web of Science ®Google Scholar
• Ashutosh K. Nitric oxide and asthma: a review. Cull- Opin Pulm Med 2000; 6: 21–25.
   PubMedGoogle Scholar
• Beckman DL, Mehta P, Hanks V, Rowan WH, Liu L. Effects of peroxynitrite on pulmonary edema and the oxidative state. Exp Lung Res 2000; 26: 349–359.
   PubMed Web of Science ®Google Scholar
• Silkof P, McClean P, Sluts AS et al. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma 1998; 35: 473–479.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Yates DH, Chung KF, Barnes P. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J1996; 9: 196-201.
   Google Scholar
• MacPherson JC, Comhair SAAA, Erzurum SC et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001; 166: 5763–5772.
   PubMed Web of Science ®Google Scholar
• Wu W, Samoszuk MK, Comhair SAAA et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 2000; 105: 1455–1463.
   PubMed Web of Science ®Google Scholar
• Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J1998; 12: 929-937.
   Google Scholar
• Ansarin K, Chatkin J, Ferreira IM, Gutierrez C, Zamel N, Chapman K. Exhaled nitric oxide in stable chronic obstructive pulmonary disease; the relationship to pulmonary function abnormalities. Eur Respir J2001; 17: 934-938.
   Google Scholar
• Maziak W, Loukides S, Culpit S, Sullivan P, Kharitonov S, Barne P. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 998–1002.
   PubMed Web of Science ®Google Scholar
• Corradi M, Majori M, Cacciani GC, Consigli GF, de'Munari E, Pesci A. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 1999; 54: 572–575.
   PubMed Web of Science ®Google Scholar
• Ferreira IM, Hazari MS, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease. Effects of inhaled beclomethasone. Am J Respir Crit Care Med 2001; 164: 1012–1015.
   PubMed Web of Science ®Google Scholar
• Fink MP. Role of reactive oxygen and nitrogen species in acute respiratory distress syndrome. Curr Opin Crit Care 2002; 8: 6–11.
   PubMedGoogle Scholar
• Zhang P, Wang YZ, Kagan E, Bonner JC. Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem 2000; 275: 22479–22486.
   PubMed Web of Science ®Google Scholar
• Groves JT. Peroxynitrite: reactive, invasive and enigmatic. Cun-Opin Chem Biol 1999; 3: 226–235.
   PubMed Web of Science ®Google Scholar
• Hogg N, Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim Biophys Acta 1999; 1411: 378–384.
   PubMed Web of Science ®Google Scholar
• Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000; 162: 1273–1276.
   PubMed Web of Science ®Google Scholar
• Kaminisky DA, Mitchell J, Carroll N, James A, Soultanakis R, Janssen Y. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma. J Allergy Clin Immunol 1999; 104: 747–754.
   PubMed Web of Science ®Google Scholar
• Balint B, Donnelly LE, Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 2001; 56: 456–461.
   PubMed Web of Science ®Google Scholar
• Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000; 162: 701–706.
   PubMed Web of Science ®Google Scholar
• Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Crit Care Respir Med 2001; 163: 854–858.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ. Dose-dependent onset and duration of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57: 889–896.
   PubMed Web of Science ®Google Scholar
• Ho LP, Times JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998; 53: 680–684.
   PubMed Web of Science ®Google Scholar
• Cunningham S, McColm JR, Ho LP, Greening AP, Marshal TG. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J2000; 15: 955-957.
   Google Scholar
• Ganas K, Loukides S, Papatheodorou G, Panagou P, Kalogeropoulos N. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001; 95: 649–654.
   PubMed Web of Science ®Google Scholar
• Lawson JA, Rokach J, FitzGerald GA. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 1999; 274: 24441–24444.
   PubMed Web of Science ®Google Scholar
• Dworski R, Murry JJ, Roberts II LJ et al. Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics: evidence for oxidant stress. Am J Respir Crit Care Med 1999; 160: 1947–1951.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Collins JV, Ciabattoni Get al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162: 1175–1177.
   PubMed Web of Science ®Google Scholar
• Stojilikovic MP, Lopes HF, Zhang D, Morrow JD, Goodfriend TL, Egan BM. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 2002; 20: 1215–1221.
   PubMed Web of Science ®Google Scholar
• Delanty N, Reilly M, Pratico D, FitzGerald DJ, Lawson JA, FitzGerald GA. 8-epiPGF2c,: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol 1996; 42: 15–19.
   PubMed Web of Science ®Google Scholar
• Longmire AW, Swift LL, Roberts II LJ, Awad JA, Burk RF, Morrow JD. Effects of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem Phannacol 1994; 47: 1173–1177.
   PubMed Web of Science ®Google Scholar
• Baraldi E, Carraro S, Alinovi R et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58: 505–509.
   PubMed Web of Science ®Google Scholar
• Fessel JP, Porter NA, Moore KP, Sheller JR, Roberts U. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci USA 2002; 99: 16713–16718.
   PubMed Web of Science ®Google Scholar
• Carpenter C, Price P, Christmas B. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury and ARDS. Chest 1998; 114: 1653–1659.
   PubMed Web of Science ®Google Scholar
• Larstad M, Ljungkvist G, Olin AC, Toren K. Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 2002; 766: 107–114.
   PubMed Web of Science ®Google Scholar
• Rahman I, van Schadewijk A, Crowther A et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product is elevated in lungs of patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2002; 166: 490–495.
   PubMed Web of Science ®Google Scholar
• Corradi M, Folesani G, Andreoli R et al. Aldehydes and glutathione in the exhaled breath condensate in children with asthma exacerbation. Am J Respir Crit Care Med 2003; 167: 395–399.
   PubMed Web of Science ®Google Scholar
• Khyshiktueva NA, Khyshiktuev BS. Prenatal diagnosis of fetal hypoxia based on lipid peroxidation values in exhaled air condensate. Klin Lab Diagn 1998; 20: 21–22.
   Google Scholar
• Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 2000; 162: 1450–1454.
   PubMed Web of Science ®Google Scholar
• Olepade CO, Zakkar M, Swedler WI. Exhaled pentane levels in acute asthma. Chest 1997; 111: 862–865.
   PubMed Web of Science ®Google Scholar
• Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthma patients. Eur Respir J1997; 10: 1235-1241.
   Google Scholar
• Tsukagoshi H, Shimizu Y, Iwamae S et al. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline. Respir Med 2000; 94: 584–588.
   PubMed Web of Science ®Google Scholar
• Paredi P, Kharitonov SA, Keak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 369–373.
   PubMed Web of Science ®Google Scholar
• Mohler 3rd ER, Reaven P, Stengner JE, Fineberg NS, Hathaway DR Gas chromatographic method using photoionisation detection for the determination of breath pentane. J Chromatogr B Biomed Appl 1996; 685: 201–209.
   PubMed Web of Science ®Google Scholar
• Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbiturate reactive acid substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999; 93: 389–396.
   PubMed Web of Science ®Google Scholar
• Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055–1060.
   PubMed Web of Science ®Google Scholar
• Lapenna D, Gioia SD, Mezzetti A et al. Cigarette smoke, ferritin, and lipid peroxidation. Am J Respir Crit Care Med 1995; 151: 431–435.
   PubMed Web of Science ®Google Scholar
• Fahn H, Wang L, Kao S, Chang S, Huang M, Wei Y. Smoking-associated mitochondrial DNA mutation and lipid peroxidation in human lung tissue. Am J Respir Cell Mol Biol 1998; 19: 901–909.
   PubMed Web of Science ®Google Scholar
• Moore K, Roberts U. Measurement of lipid peroxidation. Free Radic Res. 1998; 28: 659–671.
   PubMed Web of Science ®Google Scholar
• Miller III ER, Appel LJ, Jiang L, Risby TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96: 1097–1101.
   PubMed Web of Science ®Google Scholar
• Hunt JF, Fang K, Malik R et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161: 694–699.
   PubMed Web of Science ®Google Scholar
• Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002; 165: 1364–1370.
   PubMed Web of Science ®Google Scholar
• Scheideler L, Manke HG, Schwulera U, Inacker 0, Hammerle H. Detection of non-volatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993; 148: 778–784.
   Google Scholar
• Griese M, Noss J, von Bredow C. Protein pattern of exhaled breath condensate and saliva. Proteomics 2002; 2: 690–696.
   PubMed Web of Science ®Google Scholar
• Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 1996; 39: 70–76.
   Web of Science ®Google Scholar
• Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993; 14: 303–311.
   PubMed Web of Science ®Google Scholar
• Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234: 279–293.
   PubMed Web of Science ®Google Scholar
• Wayner DD, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total peroxyl radical-trapping antioxidant capability of human blood plasma by controlled lipid peroxidation. FEBS Lett 1985; 187: 33–37.
   PubMed Web of Science ®Google Scholar
• Kelly FJ, Buhl R, Sandstrom T. Measurement of antioxidants, oxidants and oxidant products in bronchoalveolar lavage fluid. Eur Respir Rev 1999; 9: 93–98.
   Google Scholar
• Kelly FJ, Mudway I, Blomberg A, Frew AJ, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354: 482–483.
   PubMed Web of Science ®Google Scholar
• Cross CE, van der Vilet A, O'Neil CA, Louie S, Halliwell B. Oxidants, antioxidants and respiratory tract lining fluids. Environ Health Perspect 1994; 102: 185–191.
   PubMed Web of Science ®Google Scholar
• van Wissen S, Smilde TJ, De Groot E, Hutten BA, Kastelein JJ, Stalenhoef AF. The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study. J Cardiovasc Risk 2003; 10: 451–455.
   Google Scholar
• Mortensen SA. Overview on coenzyme Q10 as adjuctive therapy in chronic heart failure. Rationale, design and en-points of ‘Q-SYMBIO’ - a multinational trial. Biofactors 2003; 18: 79–89.
   PubMed Web of Science ®Google Scholar
• Goodman GE, Schaffer S, Ommen GS, Chen C, King I. The assoc-iation between lung and prostate cancer risk and serum micro-nutrients: results and lessons learnt from beta-carotene and retinal efficacy trials. Cancer Epidemiol Biomarkers Prey 2003; 12: 518–526.
   PubMed Web of Science ®Google Scholar
• Pacht ER, De Michele SJ, Nelson JL, Hart J, Wennberg AK, Gadek JE. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with ARDS. Crit Care Med 2003; 31: 491–500.
   PubMed Web of Science ®Google Scholar
• Hogue A, Albanes D, Lippman SM et al. Molecular epidemio-logical studies within the selenium and vitamin E cancer prevention trial (SELECT). Cancer Causes Control 2001; 12: 627–633.
   PubMed Web of Science ®Google Scholar
• Gerrits CMGM, Herings RMC, Leuflcens HGM, Lammers JWJ. N-acetylcysteine reduces risk of re-hospitalisation among patients with COPD. Eur Respir J2003; 21: 795-798.
   Google Scholar
• Kaur B, Rowe BH, Ram FS. Vitamin C supplementation for asthma. Cochrane Database Syst Rev. 2001; 4: CD000993.
   PubMedGoogle Scholar
• Arab L, SteckScott S, Fleishauer AT. Lycopene and the lung. Exp Biol Med 2002; 227: 894–899.
   Web of Science ®Google Scholar
• Nathens AB, Neffon J, Jurkovich GJ et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236: 814–822.
   PubMed Web of Science ®Google Scholar
• Allard JP, Royall D, Kurian R, Muggli R, Jejeebhoy KN. Effects of beta-carotene supplementation on lipid peroxidation in humans. Am J Clin Nutr 1994; 59: 884–890.
   PubMed Web of Science ®Google Scholar
• Fogarty A, Lewis SA, Scrivener SL et al. Oral magnesium and vitamin C supplementation in asthma: a parallel group randomized placebo controlled trial. Clin Exp Allergy 2003; 33: 1355–1359.
   PubMed Web of Science ®Google Scholar